GENE

Genetic Technologies (GENE)

Genetic Technologies Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GENE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/28	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GENE	Genetic Technologies Ltd
2024/05/23	21:00	GlobeNewswire Inc.	GeneType and Humanise Health host “Know Your Risk” Event	NASDAQ:GENE	Genetic Technologies Ltd
2024/05/06	21:00	GlobeNewswire Inc.	GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/23	04:00	GlobeNewswire Inc.	Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/19	01:17	GlobeNewswire Inc.	Genetic Technologies Announces $2 Million Registered Direct Offering	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/17	21:00	GlobeNewswire Inc.	New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/16	21:00	GlobeNewswire Inc.	GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/11	21:00	GlobeNewswire Inc.	GTG to pilot GeneType in Breast Screen centers across the U.S.	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/08	21:00	GlobeNewswire Inc.	EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/02	21:05	GlobeNewswire Inc.	Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market	NASDAQ:GENE	Genetic Technologies Ltd
2024/03/26	21:00	GlobeNewswire Inc.	GTG Global Collaborations and Innovation Update	NASDAQ:GENE	Genetic Technologies Ltd
2024/03/25	21:00	GlobeNewswire Inc.	GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare	NASDAQ:GENE	Genetic Technologies Ltd
2024/02/26	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/02/15	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/02/15	04:14	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/31	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/31	22:00	GlobeNewswire Inc.	Launching our most comprehensive test and expanding into new global markets	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/09	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/05	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/05	22:00	GlobeNewswire Inc.	Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/05	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GENE	Genetic Technologies Ltd
2023/12/28	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2023/12/27	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2023/12/21	07:00	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:GENE	Genetic Technologies Ltd
2023/12/14	22:00	GlobeNewswire Inc.	GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness	NASDAQ:GENE	Genetic Technologies Ltd
2023/12/12	22:00	GlobeNewswire Inc.	Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change	NASDAQ:GENE	Genetic Technologies Ltd
2023/10/30	21:00	GlobeNewswire Inc.	Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial	NASDAQ:GENE	Genetic Technologies Ltd
2023/10/18	21:30	GlobeNewswire Inc.	GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment	NASDAQ:GENE	Genetic Technologies Ltd
2023/09/27	22:00	GlobeNewswire Inc.	GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network	NASDAQ:GENE	Genetic Technologies Ltd
2023/09/12	21:00	GlobeNewswire Inc.	Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release	NASDAQ:GENE	Genetic Technologies Ltd